pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›calendar
  3. ›recall
recall
save

F.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)

February 18, 2026updated 5mo ago
community read0 votes

Testosterone 100mg, Triamcinolone Acetonide 20mcg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC:79559-6100-32. — Reason: Presence of Foreign substance - potential presence of metal particulate matter — Status: Ongoing

view source ↗
Data sources
fda recalls
last refreshed 29m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

same company · ±60 days · 6

  • recallF.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)Feb 18, 2026
  • approvalISOTRETINOIN — FDA approvalFeb 9, 2026
  • approvalISOTRETINOIN — FDA approvalFeb 9, 2026
  • approvalABSORICA LD (ISOTRETINOIN) — FDA approvalFeb 9, 2026
  • approvalCALCITRIOL — FDA approvalFeb 27, 2026
  • approvalMYORISAN (ISOTRETINOIN) — FDA approvalFeb 9, 2026

🐶 often sniffed alongside

top 8
  • drugARYNTA31 co-mentions · 10 sources
  • drugLISDEXAMFETAMINE DIMESYLATE31 co-mentions · 10 sources
  • tagRecall30 co-mentions · 16 sources
  • companyOhm Laboratories Inc17 co-mentions · 9 sources
  • drugGralise6 co-mentions · 2 sources
  • drugNeurontin6 co-mentions · 2 sources
  • drugGABAPENTIN6 co-mentions · 2 sources
  • tagDrug Shortage4 co-mentions · 4 sources

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?